Indian Company Master Data Made Simple
Orchid Pharma Limited
Orchid Pharma Limited, with incorporation dating back to 1992, brings more than 3 decades of expertise. It is registered under CIN L24222TN1992PLC022994 and registration number 22994. It belongs to the classification of company limited by shares as per MCA records. Orchid Pharma Limited’s authorized capital amounts to ₹150.00 crore. This company’s paid-up capital is valued at ₹50.72 crore.
Its principal business sector is manufacture of other chemical products. This entity is registered in Chennai, India. The company is incorporated with the address Plot No 121-128, 128a-133, 138-151, 159-164, Sidco Industrial Estate,alathur,chengalpattu, Alathur Industrial Estate, Kanchipuram, Chengalpattu, Tamil Nadu, India, 603110. Its current corporate status is active. Orchid Pharma Limited holds PAN AAACO0402B. As per official records, the company’s LEI is 33580076KIKCYSLZVF05. Its primary communication email is cs@orchidpharma.com. Key executives of the company are: Sunil Kumar Gupta (CFO).
Company Overview
- CIN
- Date of Incorporation
- 30/06/1992
- Company Status
- Active
- RoC
- Chennai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹1,50,00,00,000.00
- Paid up Capital
- ₹50,71,91,000.00
- Activity
- Manufacture of other chemical products
- cs@orchidpharma.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Gujarat | 24AAACO0402B1ZI | Inactive |
| Haryana | 06AAACO0402B1ZG | Active |
| Himachal Pradesh | 02AAACO0402B1ZO | Inactive |
| Karnataka | 29AAACO0402B1Z8 | Inactive |
| Maharashtra | 27AAACO0402B2ZB | Inactive |
| 27AAACO0402B1ZC | Inactive | |
| Puducherry | 34AAACO0402B1ZH | Inactive |
| Rajasthan | 08AAACO0402B1ZC | Inactive |
| 08AAACO0402B2ZB | Active | |
| Tamil Nadu | 33AAACO0402B1ZJ | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE191A01027 | ORCHID PHARMA LIMITED EQ NEW FV RS. 10/- | - | 12/10/2026 | ORCHID PHARMA/SH VTG | ESVUFN |
| IN8191A01026 | ORCHID PHARMA LIMITED EQ NEW FV RS. 10/- LISTG/TRDG APRVL AWAITED | - | 12/10/2026 | ORCHID PHARMA/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹95,867.34L | ₹75,824.12L | ₹64,511.62L | ₹62,119.33L | ₹0.00L |
| Net Debt | ₹35,047.00L | ₹15,313.23L | ₹13,087.64L | ₹30,874.86L | ₹0.00L |
| Gross PPE | ₹95,867.34L | ₹1,46,167.64L | ₹1,31,431.79L | ₹1,25,828.54L | ₹0.00L |
| Inventory | ₹25,641.14L | ₹19,817.79L | ₹14,936.05L | ₹22,873.80L | ₹0.00L |
| Total Debt | ₹36,258.82L | ₹17,460.91L | ₹13,518.06L | ₹33,134.57L | ₹0.00L |
| Common Stock | ₹5,071.91L | ₹5,071.91L | ₹5,071.91L | ₹4,081.64L | ₹0.00L |
| Current Debt | ₹2,975.10L | ₹4,260.33L | ₹1,404.75L | ₹18,250.81L | ₹0.00L |
| Share Issued | ₹507.19L | ₹507.19L | ₹507.19L | ₹408.16L | ₹0.00L |
| Total Assets | ₹1,91,091.09L | ₹1,68,791.47L | ₹1,55,387.39L | ₹1,22,520.63L | ₹0.00L |
| Capital Stock | ₹5,071.91L | ₹5,071.91L | ₹5,071.91L | ₹4,081.64L | ₹0.00L |
| Long Term Debt | ₹32,772.70L | ₹13,163.58L | ₹12,042.98L | ₹14,883.76L | ₹0.00L |
| Current Assets | ₹68,389.86L | ₹80,741.73L | ₹79,075.01L | ₹50,100.97L | ₹0.00L |
| Working Capital | ₹40,492.85L | ₹52,184.77L | ₹53,077.58L | ₹12,911.80L | ₹0.00L |
| Invested Capital | ₹1,64,526.30L | ₹1,44,152.45L | ₹1,30,394.34L | ₹1,01,999.47L | ₹0.00L |
| Other Properties | ₹61,815.23L | ₹1,664.41L | ₹1,631.85L | ₹1,631.85L | ₹0.00L |
| Common Stock Equity | ₹1,28,778.50L | ₹1,26,728.54L | ₹1,16,946.61L | ₹68,864.90L | ₹0.00L |
| Net Tangible Assets | ₹1,21,410.93L | ₹1,25,027.11L | ₹1,15,454.76L | ₹68,826.33L | ₹0.00L |
| Tangible Book Value | ₹1,21,410.93L | ₹1,25,027.11L | ₹1,15,454.76L | ₹68,826.33L | ₹0.00L |
| Current Liabilities | ₹27,897.01L | ₹28,556.96L | ₹25,997.43L | ₹37,189.17L | ₹0.00L |
| Long Term Provisions | ₹1,170.40L | ₹338.72L | ₹363.37L | ₹1,260.18L | ₹0.00L |
| Stockholders Equity | ₹1,28,778.50L | ₹1,26,728.54L | ₹1,16,946.61L | ₹68,864.90L | ₹0.00L |
| Other Equity Interest | ₹1,23,706.59L | ₹6,856.06L | ₹6,856.06L | ₹6,856.06L | ₹0.00L |
| Total Capitalization | ₹1,61,551.20L | ₹1,39,892.12L | ₹1,28,989.59L | ₹83,748.66L | ₹0.00L |
| Ordinary Shares Number | ₹507.19L | ₹507.19L | ₹507.19L | ₹408.16L | ₹0.00L |
| Other Intangible Assets | ₹7,367.57L | ₹1,701.43L | ₹1,491.85L | ₹38.57L | ₹0.00L |
| Other Non Current Assets | ₹8,968.42L | ₹6,183.19L | ₹913.03L | ₹202.14L | ₹0.00L |
| Total Non Current Assets | ₹1,22,701.23L | ₹88,049.74L | ₹76,312.38L | ₹72,419.66L | ₹0.00L |
| Cash And Cash Equivalents | ₹700.80L | ₹2,110.68L | ₹360.09L | ₹2,259.71L | ₹0.00L |
| Construction In Progress | ₹34,052.11L | ₹12,632.12L | ₹2,552.32L | ₹4,848.45L | ₹0.00L |
| Other Short Term Investments | ₹7,706.60L | ₹1.59L | ₹92.29L | ₹492.36L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹7,367.57L | ₹1,701.43L | ₹1,491.85L | ₹38.57L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,28,778.50L | ₹1,26,728.54L | ₹1,16,946.61L | ₹68,864.90L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹62,312.59L | ₹42,062.93L | ₹38,440.78L | ₹53,655.73L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹3,013.64L | ₹4,293.66L | ₹1,438.08L | ₹18,250.81L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹33,245.18L | ₹13,167.25L | ₹12,079.98L | ₹14,883.76L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹8,407.40L | ₹2,112.27L | ₹452.38L | ₹2,752.07L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹34,415.58L | ₹13,505.97L | ₹12,443.35L | ₹16,466.56L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net Income | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹4,631.83L | ₹0.00L |
| Free Cash Flow | -₹28,238.57L | -₹13,089.29L | ₹6,117.72L | -₹6,657.51L | ₹0.00L |
| Changes In Cash | -₹1,409.88L | ₹1,750.59L | -₹1,899.62L | ₹1,829.05L | ₹0.00L |
| End Cash Position | ₹700.80L | ₹2,110.68L | ₹360.09L | ₹2,259.71L | ₹0.00L |
| Financing Cash Flow | ₹16,998.03L | ₹2,522.17L | ₹16,704.04L | ₹3,116.64L | ₹0.00L |
| Investing Cash Flow | -₹28,527.44L | -₹2,693.09L | -₹31,202.86L | -₹3,121.39L | ₹0.00L |
| Operating Cash Flow | ₹10,119.53L | ₹1,921.51L | ₹12,599.20L | ₹1,833.80L | ₹0.00L |
| Capital Expenditure | -₹38,358.10L | -₹15,010.80L | -₹6,481.48L | -₹8,491.31L | ₹0.00L |
| Beginning Cash Position | ₹2,110.68L | ₹360.09L | ₹2,259.71L | ₹430.66L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹3,427.54L | ₹11,010.49L | ₹10,829.97L | ₹8,747.26L | ₹0.00L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹6,972.81L | ₹14,465.07L | ₹14,153.68L | ₹14,225.94L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹4,631.83L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹28,545.20L | ₹37,770.33L | ₹32,067.97L | ₹26,872.24L | ₹0.00L |
| Pretax Income | ₹2,101.67L | ₹9,556.48L | ₹9,194.52L | ₹5,524.69L | ₹0.00L |
| Tax Provision | -₹19.16L | -₹19.35L | -₹311.91L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹81,132.73L | ₹92,192.59L | ₹81,906.63L | ₹66,589.84L | ₹0.00L |
| Cost Of Revenue | ₹52,587.53L | ₹54,422.26L | ₹49,838.66L | ₹39,717.60L | ₹0.00L |
| Total Expenses | ₹65,279.72L | ₹66,512.90L | ₹74,059.72L | ₹63,622.94L | ₹0.00L |
| Interest Expense | ₹1,325.87L | ₹1,454.01L | ₹1,635.45L | ₹3,222.57L | ₹0.00L |
| Operating Income | ₹15,853.01L | ₹25,679.69L | ₹7,846.91L | ₹2,966.90L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹7,630.16L | ₹14,465.07L | ₹14,218.79L | ₹10,225.90L | ₹0.00L |
| Normalized Income | ₹2,449.11L | ₹9,965.68L | ₹9,262.23L | ₹1,309.30L | ₹0.00L |
| Operating Expense | ₹12,692.19L | ₹12,090.64L | ₹24,221.06L | ₹23,905.34L | ₹0.00L |
| Operating Revenue | ₹81,132.73L | ₹92,192.59L | ₹81,906.63L | ₹66,589.84L | ₹0.00L |
| Net Interest Income | -₹1,325.87L | -₹1,454.01L | -₹38.75L | -₹3,228.42L | ₹0.00L |
| Total Unusual Items | -₹657.35L | ₹0.00L | -₹65.11L | ₹4,000.04L | ₹0.00L |
| Basic Average Shares | ₹507.33L | ₹507.16L | ₹483.65L | ₹408.16L | ₹0.00L |
| Diluted Average Shares | ₹507.33L | ₹507.16L | ₹483.65L | ₹408.16L | ₹0.00L |
| Reconciled Depreciation | ₹3,545.27L | ₹3,454.58L | ₹3,323.71L | ₹5,478.68L | ₹0.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹52,587.53L | ₹54,422.26L | ₹49,838.66L | ₹39,717.60L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹262.94L | ₹0.00L | -₹19.53L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹1,325.87L | ₹1,454.01L | ₹1,635.45L | ₹3,222.57L | ₹0.00L |
| Net Income Common Stockholders | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹4,631.83L | ₹0.00L |
| Net Income Continuous Operations | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹5,309.34L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹4,631.83L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹657.35L | ₹0.00L | -₹65.11L | ₹4,000.04L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹1,325.87L | -₹1,454.01L | -₹38.75L | -₹3,228.42L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹4,631.83L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹4,631.83L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹2,054.70L | ₹9,965.68L | ₹9,216.65L | ₹5,309.34L | ₹0.00L |
Company Performance (FY23–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 31/03/2020 | Ram Gopal Agarwal | 00627386 | Director | View other directorships |
| 31/03/2020 | Mridul Dhanuka | 00199441 | Whole-time director | View other directorships |
| 31/03/2020 | Manish Dhanuka | 00238798 | Managing Director | View other directorships |
| 29/06/2020 | Dharam Vir | 08771224 | Director | View other directorships |
| 29/06/2020 | Tanu Singla | 08774132 | Director | View other directorships |
| 29/06/2020 | Manoj Kumar Goyal | 06361663 | Director | View other directorships |
| 29/06/2020 | Sunil Kumar Gupta | *****7868R | CFO | |
| 20/10/2023 | Arjun Dhanuka | 00454689 | Director | View other directorships |
| 16/12/2023 | Kapil Dayya | *****5921P | Company Secretary | |
| 23/05/2024 | Shubha Singh | 06926872 | Director | View other directorships |
Business Network
Directors 10
- Manish DhanukaManaging Director
- Mridul DhanukaWhole-time director
- Shubha SinghDirector
- Arjun DhanukaDirector
- Dharam VirDirector
- Manoj Kumar GoyalDirector
- Tanu SinglaDirector
- Ram Gopal AgarwalDirector
- Kapil DayyaCompany Secretary
- Sunil Kumar GuptaCFO
Subsidiaries 1
- Orchid Bio-pharma LimitedDirect
Latest Documents
| Date | Title | Size |
|---|---|---|
| 03/12/2024 | Form AOC-4(XBRL)-03122024-signed | - |
| 19/10/2024 | Form MGT-7-19102024_signed | - |
| 18/09/2024 | Form AOC-4(XBRL)-18092024 | - |
| 30/03/2024 | Form Addendum to AOC-4 CSR-30032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Asian Paints Limited | L24220MH1945PLC004598 | 6a & 6b, Shantinagar, Santacruz(east), Mumbai, Mumbai, Maharashtra, India, 400055 |
| Bombay Paints Limited | L24220MH1948PLC006834 | B D Patil Marg, Gavanpada Chembur Mumbai Mh 400074 In |
| Organic Coatings Limited | L24220MH1965PLC013187 | Unit No.405, Atlanta Estate Premises Coopsoc.ltd. Vith Bhatti Nr Virwani Industrial Estate, Goregaon E, Mumbai City, Mumbai, Maharashtra, India, 400063 |
| Sarika Paints Ltd | L24220GJ1989PLC012463 | 56 Ellis Shopping Centreellisbridge, Ahmedabad, Ahmedabad, Gujarat, India, 380006 |
| Sashwat Technocrats Limited | L24220MH1975PLC018682 | Office No.14, First Floor, Plumber House, 557, J. S. S. Road, Chira Bazar, Mumbai City, Mumbai, Maharashtra, India, 400002 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Orchid Bio-pharma Limited | 98450011B7C3HY6A6014 |
Address
Frequently Asked Questions
The current board member of Orchid Pharma Limited are:
- Ram Gopal Agarwal
- Mridul Dhanuka
- Dharam Vir
- Tanu Singla
- Manoj Kumar Goyal
- Manish Dhanuka
- Shubha Singh
- Arjun Dhanuka